Autres langues Quest Diagnostics Incorporated

Actions

DGX

US74834L1008

Temps réel estimé Cboe BZX Autres places de cotation 21:09:11 29/04/2024			Varia. 5j.	Varia. 1 janv.
139,6 ^USD	+3,95 %		+7,31 %	+1,24 %

15:55	La FDA américaine publie la règle finale pour les tests développés en laboratoire	RE
25/04	Labcorp dépasse ses estimations trimestrielles grâce à une forte demande de tests	RE

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

US FDA publishes final rule for laboratory developed tests	15:55
Quest Diagnostics Foundation and Green Bronx Machine Expand Collaboration To Bring Acclaimed Indoor Gardening Curriculum to More Communities and Raise Awareness for Impact of Nutrition Education on Health Equity	26/04
Fitch Affirms Quest Diagnostics at 'BBB'; Outlook Remains Positive	26/04
Labcorp beats quarterly estimates on strong testing demand	25/04
Quest Diagnostics Reports First Quarter 2024 Financial Results, Raises Guidance for Full Year 2024	24/04
Quest Diagnostics Incorporated : First Quarter 2024 View Transcript of Company Prepared Comments	23/04
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	23/04
Quest Diagnostics Posts Flat Q1 Adjusted Earnings, Revenue Rises; 2024 Earnings, Revenue Guidance Raised	23/04
Earnings Flash (DGX) QUEST DIAGNOSTICS Reports Q1 Revenue $2.37B, vs. Street Est of $2.29B	23/04
Earnings Flash (DGX) QUEST DIAGNOSTICS Posts Q1 EPS $2.04, vs. Street Est of $1.86	23/04
Quest Diagnostics: Q1 Earnings Snapshot	23/04
Quest Diagnostics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
Quest Diagnostics Reports First Quarter 2024 Financial Results; Raises Guidance for Full Year 2024	23/04
Quest Diagnostics Incorporated Updates Earnings Guidance for the Full Year of 2024	23/04
MORNING BID AMERICAS-Tanking Tesla reports, Europe business beats	23/04
Quest Diagnostics Launches New Test to Help Assess Alzheimer's Disease Risk	22/04
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	22/04
Quest Diagnostics Adds p-tau217 Blood Biomarker Testing to Suite of Services Designed to Assess Risk and Help Aid Diagnosis of Alzheimer's Disease	22/04
John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission	11/04
Quest Diagnostics Receives Shareholder Proposal from John Chevedden	05/04

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Quest Diagnostics Incorporated

Actions

DGX

US74834L1008

Autres langues

Filtres